Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System® includes three components: Zoë® Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease—offering researchers a new technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. 

Research conducted using our Organ-Chips has been published in high-impact scientific journals, including Science. In addition, Organ-Chips have been acquired by the Museum of Modern Art (MoMA) in New York for their permanent collection and have also been awarded Product Design of the Year 2015 by London’s Design Museum.

Alumni Ventures

SciFi VC

Beyond Impact Advisors

Glass Wall Syndicate

Founders Fund

ALS Investment Fund

Starlight Ventures

Northpond Ventures

Perceptive Advisors

Ethos Family Office

Emulate, Inc.

Prof. Hazel Screen from QMUL School of Engineering joined Operation Ouch to unravel the wonders of Organ-on-a-Chip technology for a younger audience, introducing a new generation to the power of human-relevant in vitro models. Learn more in this exclusive Q&A! https://bit.ly/47OdTHB

And the #MicroscopyMonday post with the most votes in 2023 is… this Alveolus Lung-Chip image! Using a Chip-A1 prototype, scientists grew alveolar cells on top of a stromal compartment, resulting in this supernova-like biology. Learn more about the Chip-A1: https://bit.ly/48rxwpz #OrganChips #Research

We are excited to announce that the University of St Andrews has been selected as the winner of the Emulate Infectious Disease Grant! This collaborative group of researchers will be applying Emulate Organ-on-a-Chip technology to help further their understanding of how viruses, bacteria, and parasites cause infection and disease as well as how these infectious diseases can be prevented and treated.

Coming in at second-place for 2023, this #MicroscopyMonday image shows strong barrier formation of colon epithelial cells (yellow ZO-1 staining) on a Colon Intestine-Chip prepared for immune cell recruitment (ICR). Learn more on our ICR application here: https://bit.ly/48nROQF

Over the next 3 weeks, we’re bringing back the most popular #MicroscopyMonday posts of 2023! Up first: Scientists developed a Skin-Chip model using the new Emulate Chip-A1 Accessible Chip, allowing them to capture these detailed images of the epidermis and fibroblasts within the 3D chamber. Join the Chip-A1 early access program now: https://bit.ly/3GFLE2K #OrganChips #Research #DrugDevelopment

InSphero is a company that provides 3D cell-based assay solutions for drug discovery and development.

InSphero

Mimetas is a company specializing in organ-on-a-chip technology for drug development and personalized medicine.

Mimetas

AxoSim is a biotechnology company focused on developing nerve-on-a-chip platforms for drug testing and disease modeling.

AxoSim

Mindstrong Health is a healthcare technology company that uses digital biomarkers to improve mental health diagnosis and treatment.

Mindstrong Health

Peerfit is a company that offers a digital platform for corporate wellness programs and fitness benefits.

Peerfit

Docent Health is a healthcare technology company that focuses on patient experience and engagement solutions for healthcare providers.

Docent Health

MDsave Inc is a healthcare technology company that offers a platform for transparent healthcare pricing and medical cost savings.

MDsave Inc

Emulate, Inc. is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model organs in healthy and diseased states. The technology has applications in pharmaceutical research, product development, and testing how different medicines, chemicals, and foods affect human health. Emulate has also worked with Cedars-Sinai Medical Center on a precision medicine initiative that uses Organs-on-Chips technology in the clinical setting.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 16, 2024 9:47 PM	2a270f36
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 16, 2024 9:47 PM	4c04f46d
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	cd73bde4
crunchbase profile	general
li profile	general	Feb 16, 2024 9:47 PM	06282b82
translate crunchbase fundingrounds	general
peers	general	Feb 16, 2024 9:47 PM	ff6582d8
news basic	general	Feb 16, 2024 9:47 PM	a85d0974
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:EMULATEBIO

Emulate, Inc.